Scientists develop scans that light up aggressive cancer tumors for better treatment
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...
WebMD1d
FDA Approves New Drug for Advanced Skin Cancer
The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.
Medscape1d
FDA Approves Cosibelimab for Cutaneous SCC
L1-blocking antibody is now approved for metastatic or locally advanced cutaneous SCC in adults who are not candidates for curative surgery or curative radiation.
Too Old to Operate1d
Approaches for Identifying Uncertain Tumor Locations in Skin Cancer Surgery
The following is a summary of “How dermatologic surgeons decide to proceed with surgery for nonmelanoma skin cancer when site ...